Enyglid
Active substance: repaglinide
repaglinide
Centralised EU authorisationActive
Marketing holder: Krka, d.d., Novo mesto
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 7 |
|
| US 20 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-38ab-7963-a675-473937f132a7,01a120c3-515f-73d7-ada2-47756de960d7,01a120c4-de6d-76ef-9ebf-3f644517e322,01a120c5-2028-7114-8cb7-ee979f79fb6f,01a120c5-a416-7a8f-8a92-55a06d61e485;count=5 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-299c-7f13-87ac-4eef0aede2c0,01a1208c-8463-7ce0-a68d-7589a5992c2a,01a1208d-07d7-75db-9888-3f410d354034,01a1208d-7ae7-72a7-98da-8eab896d5e9b,01a1208d-bbab-78de-a68f-a548236f8e5f;count=20 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/001065
- Registration status
- Active
- ATC code
- A10BX02
- product · EMA · EMEA/H/C/001065 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/001065 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/001065 · Verified 2026-10-09